Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Joseph O. Moore
ResearcherPublications, citations & collaboration network
Joseph O. Moore is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 234 works, 11,445 citations, an h-index of 54 and an i10-index of 119.
234
Works
11,445
Citations
54
h-index
119
i10-index
IDs:OpenAlex
How has Joseph O. Moore's publication output changed over time?
ScholarIQpublication output · 1994–2020
Output grew0% over the shown period — from 1 works in 1994 to 1 in 2020.
1
2
1
1
1
1
1
1
1
1
1994199519961999200520072014201720182020
What are the most-cited papers on Joseph O. Moore?
ScholarIQmost cited works
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Robert J. Mayer, Roger B. Davis, Charles A. Schiffer, Deborah Berg, Bayard L. Powell, Philip Schulman, George Omura, Joseph O. Moore, O. Ross McIntyre, E Frei
New England Journal of Medicine. 19941,433 CitationsOPEN ACCESS
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud, Jessica K. Altman, Frederick R. Appelbaum, Daniel A. Arber, Vijaya Raj Bhatt, Dale L. Bixby, William Blum, Steven Coutré, Marcos de Lima, Amir T. Fathi, Melanie Fiorella, James M. Foran, Steven D. Gore, Aric C. Hall, Patricia Kropf, Jeffrey E. Lancet, Lori J. Maness, Guido Marcucci, Michael G. Martin, Joseph O. Moore, Rebecca L. Olin, Deniz Peker, Daniel A. Pollyea, Keith W. Pratz, Farhad Ravandi, Paul J. Shami, Richard M. Stone, Stephen A. Strickland, Eunice S. Wang, Matthew J. Wieduwilt, Kristina M. Gregory, Ndiya Ogba
Journal of the National Comprehensive Cancer Network. 2017656 CitationsOPEN ACCESS
Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia
Richard M. Stone, Deborah Berg, Stephen L. George, Richard K. Dodge, Paolo Alberto Paciucci, Philip Schulman, Edward J. Lee, Joseph O. Moore, Bayard L. Powell, Charles A. Schiffer
New England Journal of Medicine. 1995455 CitationsOPEN ACCESS
Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered
John C. Byrd, Richard K. Dodge, Andrew J. Carroll, Maria R. Baer, Colin G. Edwards, Judith Stamberg, Mazin Β. Qumsiyeh, Joseph O. Moore, Robert J. Mayer, Frederick R. Davey, Charles A. Schiffer, Clara D. Bloomfield
Journal of Clinical Oncology. 1999312 Citations
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
Isidore Tepler, Laurence Elias, John W. Smith, Mohamad A. Hussein, Gerald Rosen, A. Y. Chang, Joseph O. Moore, Michael S. Gordon, Bernice Kuca, Kathleen J. Beach, John W. Loewy, Marc B. Garnick, James A. Kaye
PubMed. 1996305 Citations
Related on ScholarIQ
Johns Hopkins University
Institution
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Paper
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Paper
Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia
Paper
Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered
Paper
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
Paper